Skip to content

Morgan Stanley MSDL Common stock, shares authorized (in shares)

Common stock, shares authorized (in shares) at other companies

Blue Owl Capital logo
Blue Owl CapitalOBDC
MidCap Financial Investment Corporation logo
MidCap Financial Investment CorporationMFIC
Oaktree Specialty Lending logo
Oaktree Specialty LendingOCSL
Prospect Capital logo
Prospect CapitalPSEC
Goldman Sachs BDC logo
Goldman Sachs BDCGSBD
Golub Capital logo
Golub CapitalGBDC

Other financials

Income statement

See full
Net income-$4.5M-115%
EPS (diluted)-$0.05-115%

Balance sheet

See full
Cash & equivalents$80.7M+16.2%
Total debt$2.1B+2.2%
Total equity$1.7B-7.0%
Total assets$3.8B-2.2%

Cash flow

See full
Operating cash flow$86.3M+153%

Valuation

See full
Market cap$1.27B-24.4%
Enterprise value$3.25B-10.4%
P/E14.5×+5.8×

Returns & leverage

See full
Return on equity5%-5.6pp
Debt / equity1.2×+0.1×

Where this comes from

Reported directly by Morgan Stanley in its filing.

Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.

The official record: Morgan Stanley’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Morgan Stanley's common stock, shares authorized (in shares).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Morgan Stanley's common stock, shares authorized (in shares)?
Morgan Stanley (MSDL) reported common stock, shares authorized (in shares) of $500M in Q1 2026.
How has Morgan Stanley's common stock, shares authorized (in shares) changed year-over-year?
Morgan Stanley's common stock, shares authorized (in shares) decreased by 0.0% year-over-year, from $500M to $500M.
What is the long-term trend for Morgan Stanley's common stock, shares authorized (in shares)?
Over 3 years (2022 to 2025), Morgan Stanley's common stock, shares authorized (in shares) has grown at a 71.0% compound annual growth rate (CAGR), from $100M to $500M.